63 related articles for article (PubMed ID: 26274756)
1. One-year mortality in patients with bone and soft tissue sarcomas as an indicator of delay in presentation.
Nandra R; Hwang N; Matharu GS; Reddy K; Grimer R
Ann R Coll Surg Engl; 2015 Sep; 97(6):425-33. PubMed ID: 26274756
[TBL] [Abstract][Full Text] [Related]
2. What is the Incidence of Suicide in Patients with Bone and Soft Tissue Cancer? : Suicide and Sarcoma.
Siracuse BL; Gorgy G; Ruskin J; Beebe KS
Clin Orthop Relat Res; 2017 May; 475(5):1439-1445. PubMed ID: 27896676
[TBL] [Abstract][Full Text] [Related]
3. Towards applying NMR relaxometry as a diagnostic tool for bone and soft tissue sarcomas: a pilot study.
Masiewicz E; Ashcroft GP; Boddie D; Dundas SR; Kruk D; Broche LM
Sci Rep; 2020 Aug; 10(1):14207. PubMed ID: 32848198
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation-based profiling of bone and soft tissue tumours: a validation study of the 'DKFZ Sarcoma Classifier'.
Lyskjaer I; De Noon S; Tirabosco R; Rocha AM; Lindsay D; Amary F; Ye H; Schrimpf D; Stichel D; Sill M; Koelsche C; Pillay N; Von Deimling A; Beck S; Flanagan AM
J Pathol Clin Res; 2021 Jul; 7(4):350-360. PubMed ID: 33949149
[TBL] [Abstract][Full Text] [Related]
5. Which indicators of early cancer diagnosis from population-based data sources are associated with short-term mortality and survival?
Muller P; Walters S; Coleman MP; Woods L
Cancer Epidemiol; 2018 Oct; 56():161-170. PubMed ID: 30056051
[TBL] [Abstract][Full Text] [Related]
6. Enhanced accuracy and reduced delay in diagnosing bone tumors within an expert sarcoma network: A nationwide study.
Crenn V; Lataste F; Galmiche L; Le Nail LR; Ropars M; Blay JY; de Pinieux G; Gouin F
Eur J Surg Oncol; 2024 Mar; 50(6):108271. PubMed ID: 38522331
[TBL] [Abstract][Full Text] [Related]
7. Spatially Fractionated Radiation Therapy in Sarcomas: A Large Single-Institution Experience.
Ahmed SK; Petersen IA; Grams MP; Finley RR; Haddock MG; Owen D
Adv Radiat Oncol; 2024 Mar; 9(3):101401. PubMed ID: 38495033
[TBL] [Abstract][Full Text] [Related]
8. Benchmarking Time-to-Treatment Initiation in Sarcoma Care Using Real-World-Time Data.
Schärer M; Heesen P; Bode-Lesniewska B; Studer G; Fuchs B;
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136394
[TBL] [Abstract][Full Text] [Related]
9. Enhancing Healthcare for Sarcoma Patients: Lessons from a Diagnostic Pathway Efficiency Analysis.
Elyes M; Heesen P; Schelling G; Bode-Lesniewska B; Studer G; Fuchs B;
Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835586
[TBL] [Abstract][Full Text] [Related]
10. The Survival Outcomes, Prognostic Factors and Adverse Events following Systemic Chemotherapy Treatment in Bone Sarcomas: A Retrospective Observational Study from the Experience of the Cancer Referral Center in Northern Thailand.
Sirikul W; Buawangpong N; Pruksakorn D; Charoentum C; Teeyakasem P; Koonrungsesomboon N
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046640
[TBL] [Abstract][Full Text] [Related]
11. Brachytherapy in the Treatment of Soft-Tissue Sarcomas of the Extremities-A Current Concept and Systematic Review of the Literature.
Neugebauer J; Blum P; Keiler A; Süß M; Neubauer M; Moser L; Dammerer D
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831476
[TBL] [Abstract][Full Text] [Related]
12. Management and Outcomes of Older Patients (Age ≥ 70 Years) with Advanced Soft Tissue Sarcoma and Role of Geriatric Assessment and Oncological Multidimensional Prognostic Index (Onco-MPI) in a Real-World Setting.
Chiusole B; Tortorelli I; Galiano A; Murtas F; Ahcene-Djaballah S; Tierno G; Bergo E; Banzato A; Gatti M; Di Maggio A; Sergi G; Rastrelli M; Sbaraglia M; Zagonel V; Brunello A
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831386
[No Abstract] [Full Text] [Related]
13. Intratumoral STING activation causes durable immunogenic tumor eradication in the KP soft tissue sarcoma model.
Marritt KL; Hildebrand KM; Hildebrand KN; Singla AK; Zemp FJ; Mahoney DJ; Jirik FR; Monument MJ
Front Immunol; 2022; 13():1087991. PubMed ID: 36700206
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of pediatric sarcoma in Iran.
Azizmohammad Looha M; Akbari A; Akbari ME; Zarean E; Mehrvar N; Khodakarim S
Cancer Rep (Hoboken); 2023 Jan; 6(1):e1660. PubMed ID: 35761437
[TBL] [Abstract][Full Text] [Related]
15. Development and comparison of 1-year survival models in patients with primary bone sarcomas: External validation of a Bayesian belief network model and creation and external validation of a new gradient boosting machine model.
Holm CE; Grazal CF; Raedkjaer M; Baad-Hansen T; Nandra R; Grimer R; Forsberg JA; Petersen MM; Skovlund Soerensen M
SAGE Open Med; 2022; 10():20503121221076387. PubMed ID: 35154743
[TBL] [Abstract][Full Text] [Related]
16. Association between occupational exposures and sarcoma incidence and mortality: systematic review and meta-analysis.
Edwards D; Voronina A; Attwood K; Grand'Maison A
Syst Rev; 2021 Aug; 10(1):231. PubMed ID: 34389054
[TBL] [Abstract][Full Text] [Related]
17. The Nomogram for Early Death in Patients with Bone and Soft Tissue Tumors.
Xu Y; Xu G; Wu H; Lin F; Mao M; Baklaushev VP; Chekhonin VP; Peltzer K; Wang J; Wang G; Wang X; Zhang C
J Cancer; 2020; 11(18):5359-5370. PubMed ID: 32742482
[No Abstract] [Full Text] [Related]
18. Intraoperative radiotherapy with low energy x-rays for primary and recurrent soft-tissue sarcomas.
Sarria GR; Petrova V; Wenz F; Abo-Madyan Y; Sperk E; Giordano FA
Radiat Oncol; 2020 May; 15(1):110. PubMed ID: 32410696
[TBL] [Abstract][Full Text] [Related]
19. The sarcoma diagnostic interval: a systematic review on length, contributing factors and patient outcomes.
Soomers V; Husson O; Young R; Desar I; Van der Graaf W
ESMO Open; 2020 Feb; 5(1):. PubMed ID: 32079621
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Mortality of Sarcomas in Shanghai, China, During 2002-2014.
Pingping B; Yuhong Z; Weiqi L; Chunxiao W; Chunfang W; Yuanjue S; Chenping Z; Jianru X; Jiade L; Lin K; Zhengdong C; Weibin Z; Chen F; Yang Y
Front Oncol; 2019; 9():662. PubMed ID: 31380289
[No Abstract] [Full Text] [Related]
[Next] [New Search]
